Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:ACXP 8 October 2025

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

Acurx Pharmaceuticals shares have fallen about 90% from their 52-week high, trading near $4.30 after a 1-for-20 reverse split in August. The stock briefly rallied in late September after the European Medicines Agency issued a positive opinion on its pediatric plan for ibezapolstat. Acurx remains pre-revenue with $6.1 million in cash at Q2’s end and faces additional funding needs for Phase 3 trials.
8 October 2025
·

Stock Market Today

  • GE Aerospace vs. Textron: Evaluating Aerospace & Defense Stock Prospects
    March 20, 2026, 1:12 PM EDT. GE Aerospace and Textron Inc. are key competitors in the aerospace and defense industry, benefiting from rising air traffic and expanding U.S. defense budgets. GE Aerospace's strength lies in its engine platforms like LEAP, GEnx, and GE9X, securing over 500 engine wins at the 2025 Dubai Airshow and a $5 billion U.S. Air Force contract for F110 engines. The company plans substantial investments exceeding $2 billion by 2026 in MRO (Maintenance, Repair, and Overhaul) and manufacturing facilities. GE also increased dividends and authorized a $20 billion share buyback. Textron's Aviation unit saw 16.2% revenue growth in 2025 fueled by commercial air travel's recovery. Both firms face growth opportunities but differ in scale and strategic focus. Investors should weigh GE's broad engine portfolio and defense contracts against Textron's aviation segment momentum.
Go toTop